Optas, LLC Bristol Myers Squibb CO Transaction History

Optas, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$57.89 - $64.73 $31,318 - $35,018	-541 Reduced 11.94%	3,991 $231,000
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $39,627 - $44,000	622 Added 15.91%	4,532 $289,000
Q1 2023 Apr 17, 2023	SELL	$65.71 - $74.53 $33,380 - $37,861	-508 Reduced 11.5%	3,910 $271,000
Q4 2022 Jan 27, 2023	SELL	$68.48 - $81.09 $15,271 - $18,083	-223 Reduced 4.8%	4,418 $317,000
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $52 - $31,197	406 Added 9.59%	4,641 $330,000
Q2 2022 Aug 01, 2022	BUY	$72.62 - $79.98 $51,923 - $57,185	715 Added 20.31%	4,235 $326,000
Q1 2022 Apr 26, 2022	BUY	$61.48 - $73.72 $19,366 - $23,221	315 Added 9.83%	3,520 $258,000
Q4 2021 Jan 26, 2022	BUY	$53.63 - $62.52 $171,884 - $200,376	3,205 New	3,205 $200,000
Q3 2021 Oct 14, 2021	SELL	$59.17 - $69.31 $182,835 - $214,167	-3,090 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$61.91 - $67.42 $191,301 - $208,327	3,090 New	3,090 $207,000
Q4 2020 Jan 27, 2021	SELL	$57.74 - $65.43 $225,705 - $255,765	-3,909 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$57.43 - $63.64 $5,398 - $5,982	94 Added 2.46%	3,909 $236,000
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $209,138 - $244,503	3,815 New	3,815 $225,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

Stay updated on Optas, LLC with notifications on news.